Literature DB >> 18087648

Insights of priapism mechanism and rationale treatment for recurrent priapism.

Jiuhong Yuan1, Rowena Desouza, O Lenaine Westney, Run Wang.   

Abstract

Priapism is defined as abnormal prolonged penile erection occurring beyond or unrelated to sexual interest. The disorder is enigmatic yet devastating because of its elusive etiology, irreversible erectile tissue damage, and resultant erectile dysfunction (ED). Current management strategies suffer from a poor understanding of the pathophysiology, especially at the molecular level. The traditional treatments are based more on empirical rather than evidence-based knowledge. The outcomes for restoration of normal erectile function are poor, especially for stuttering priapism. Therefore, it is critical to understand priapism from a molecular level, to formulate treatment strategies and to establish rational prevention strategies for high-risk populations, such as sickle cell disease (SCD) patients and cases of the stuttering variant. This review focuses on the recent advances at the molecular level in priapism and penile erection, and applies the recent knowledge to the treatment of stuttering priapism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18087648     DOI: 10.1111/j.1745-7262.2008.00314.x

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  18 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

3.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 4.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

Review 5.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

6.  Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease?

Authors:  Belinda F Morrison; Uzoma A Anele; Marvin E Reid; Wendy A Madden; Zhaoyong Feng; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-11-05       Impact factor: 2.370

Review 7.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

8.  Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.

Authors:  Shibo Fu; Moses Tarndie Tar; Arnold Melman; Kelvin Paul Davies
Journal:  FASEB J       Date:  2014-05-06       Impact factor: 5.191

Review 9.  Priapism: pathophysiology and the role of the radiologist.

Authors:  J E Halls; D V Patel; M Walkden; U Patel
Journal:  Br J Radiol       Date:  2012-09-06       Impact factor: 3.039

10.  The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway.

Authors:  Nirmala Devi Kanika; Moses Tar; Yuehong Tong; Dwaraka Srinivasa Rao Kuppam; Arnold Melman; Kelvin Paul Davies
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.